Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loris De Cecco

Showing results (101-110 of 169) with videos related to

Pageof 17
Sort By:
Oncotarget|September 4, 2015
Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltrationTiziana Triulzi, Loris De Cecco, Marco Sandri, et al.
Frontiers in Oncology|November 10, 2018
Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein InteractionLaura Caleca, Irene Catucci, Gisella Figlioli, et al.
Journal of Proteome Research|December 18, 2023
Impact of Cold Ischemia on the Stability of <sup>1</sup>H-MRS-Detected Metabolic Profiles of Ovarian Cancer SpecimensAlessandro Ricci, Matteo Dugo, Maria Elena Pisanu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2016
Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to CetuximabPaolo Bossi, Cristiana Bergamini, Marco Siano, et al.
Oncotarget|September 15, 2016
CDCP1 is a novel marker of the most aggressive human triple-negative breast cancersFederica Turdo, Francesca Bianchi, Patrizia Gasparini, et al.
Biomarker Research|July 16, 2023
MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signaturesAnna Corti, Loris De Cecco, Stefano Cavalieri, et al.
Disease Markers|December 21, 2017
Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?Paolo Bossi, Marco Siano, Cristiana Bergamini, et al.
International Journal of Cancer|March 20, 2009
FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lungFelicia S Falvella, Elisa Frullanti, Antonella Galvan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 13, 2018
Transcriptional analysis distinguishes breast implant-associated anaplastic large cell lymphoma from other peripheral T-cell lymphomasArianna Di Napoli, Loris De Cecco, Pier Paolo Piccaluga, et al.
Frontiers in Oncology|September 29, 2025
Circulating tumor DNA to anticipate loco-regional recurrence in early-stage breast cancer: a proof-of-concept studyValentina Appierto, Elena Tamborini, Paola Tiberio, et al.
Pageof 17

Showing results (101-110 of 169) with videos related to

Sort By:
Pageof 17
Oncotarget|September 4, 2015
Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltrationTiziana Triulzi, Loris De Cecco, Marco Sandri, et al.
Frontiers in Oncology|November 10, 2018
Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein InteractionLaura Caleca, Irene Catucci, Gisella Figlioli, et al.
Journal of Proteome Research|December 18, 2023
Impact of Cold Ischemia on the Stability of <sup>1</sup>H-MRS-Detected Metabolic Profiles of Ovarian Cancer SpecimensAlessandro Ricci, Matteo Dugo, Maria Elena Pisanu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2016
Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to CetuximabPaolo Bossi, Cristiana Bergamini, Marco Siano, et al.
Oncotarget|September 15, 2016
CDCP1 is a novel marker of the most aggressive human triple-negative breast cancersFederica Turdo, Francesca Bianchi, Patrizia Gasparini, et al.
Biomarker Research|July 16, 2023
MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signaturesAnna Corti, Loris De Cecco, Stefano Cavalieri, et al.
Disease Markers|December 21, 2017
Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?Paolo Bossi, Marco Siano, Cristiana Bergamini, et al.
International Journal of Cancer|March 20, 2009
FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lungFelicia S Falvella, Elisa Frullanti, Antonella Galvan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 13, 2018
Transcriptional analysis distinguishes breast implant-associated anaplastic large cell lymphoma from other peripheral T-cell lymphomasArianna Di Napoli, Loris De Cecco, Pier Paolo Piccaluga, et al.
Frontiers in Oncology|September 29, 2025
Circulating tumor DNA to anticipate loco-regional recurrence in early-stage breast cancer: a proof-of-concept studyValentina Appierto, Elena Tamborini, Paola Tiberio, et al.
Pageof 17